Summary

The global Stress Urinary Incontinence market was valued at USD 3,770.83 million in 2025 and is projected to reach USD 8,520.25 million by 2035. The market is expected to register a CAGR of 8.51% during the forecast period, driven by the growing prevalence of urinary disorders and increasing awareness regarding advanced treatment options.

Rising Preference for Minimally Invasive Treatments
The global stress urinary incontinence market is seeing rapid growth, largely driven by the increasing use of minimally invasive surgeries like mid-urethral slings and bulking agents. These procedures not only have high success rates but also ensure quicker recovery, less hospitalization, and fewer complications after surgery, hence they are the most natural preference of patients along with doctors.

Segmental Growth Highlights
Product Type
- Therapeutic or Interventional Devices - Effective procedures increase long-term treatment adoption rates.
- Absorbent Products - Disposable product usage continues growing among elderly patients.
End User
- Hospitals - Availability of skilled professionals strengthens treatment accessibility.
- Specialty Clinics - Dedicated continence care services improve patient satisfaction.
- Ambulatory Surgical Centres - Minimally invasive surgeries increase outpatient centre utilization.
- Home Care Settings - Home-based support enhances comfort for aging populations.
- Others - Continuous healthcare investments create additional market opportunities.

One of the top regions dominating the stress urinary incontinence market is North America due to its advanced healthcare facilities, the high prevalence of the disease, and the adoption of minimally invasive methods, whereas in Europe, growth is still based on well-established healthcare systems and increased awareness. In addition to that, Asia-Pacific is becoming the quickest growing region because of better healthcare investments and elder population, whereas gradually South America and the Middle East & Africa are moving forward thanks to healthcare expansion and increased awareness.

Expansion of Obstetrics Portfolio
In an effort to develop their women's health product line, Laborie made a move in January 2026 by acquiring JADA System, a device approved by FDA for fast postpartum haemorrhage control. Through this acquisition, the company not only expanded its obstetrics product line but also doubled its efforts in maternal care advancement through patient-centred treatment solutions that feature innovation.

Smart Implant Technologies Enhancing Treatment Precision
Introduction of electronic Artificial Urinary Sphincters (eAUS) into Stress Urinary Incontinence market helps the manufacturer differentiate their product while improving the customization of healthcare and at the same time reducing the risks of complications that usually come with the use of traditional devices. Fine examples of this include UroActive System, a sophisticated device that has gained support from the FDA and ANSM clinical approvals, which also reveals how MEMS-based technologies continue to lead the way in providing better and safer continence management solutions.

Key Report Attributes
- Market Size 2025: USD 3,770.83 Million
- Market Size 2035: USD 8,520.25 Million
- CAGR (2025-2035): 8.51%
- Base Year: 2024
- Market Forecast Period: 2025-2035

Industry Segmentations Growth
- By Product Type: Therapeutic or Interventional Devices - 10.16%, Absorbent Products - 7.92%.
- By End User: Hospitals - 8.38%, Specialty Clinics - 6.82%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ........................................... 22
1.1 OVERVIEW ....................... 22
1.2 MARKET ATTRACTIVENESS ANALYSIS ......................... 23
1.3 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE .................. 24
1.4 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY END USER .......................... 25
1.5 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY REGION .............................. 26
2 MARKET INTRODUCTION ....................................... 28
2.1 DEFINITION ...................... 28
2.2 SCOPE OF THE STUDY ...... 28
2.3 RESEARCH OBJECTIVE ..... 28
2.4 MARKET STRUCTURE ........ 29
3 RESEARCH METHODOLOGY ................................. 30
3.1 OVERVIEW ....................... 30
3.2 DATA FLOW ..................... 32
3.2.1 DATA MINING PROCESS ...................................... 32
3.3 PURCHASED DATABASE: ............................................. 33
3.4 SECONDARY SOURCES:..... 34
3.4.1 SECONDARY RESEARCH DATA FLOW: .................. 35
3.5 PRIMARY RESEARCH: ....... 36
3.5.1 PRIMARY RESEARCH DATA FLOW: ...................... 37
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......................... 38
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ............ 39
3.6.1 REVENUE ANALYSIS APPROACH .......................... 39
3.7 DATA FORECASTING ........ 40
3.7.1 DATA FORECASTING TYPE ................................... 40
3.8 DATA MODELING .............. 41
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ................. 41
3.8.2 DATA MODELING: ..... 42
3.9 TEAMS AND ANALYST CONTRIBUTION ......................... 44
4 MARKET DYNAMICS ............................................... 46
4.1 INTRODUCTION ................ 46
4.2 DRIVERS .......................... 47
4.2.1 HIGH PREVALENCE IN POST-PROSTATECTOMY PATIENTS .............................. 47
4.2.2 ADOPTION OF MINIMALLY INVASIVE SLING AND BULKING PROCEDURES ......... 47
4.2.3 GROWING DEMAND FOR HOME CARE ABSORBENT PRODUCTS ......................... 48
4.2.4 RISING TECHNOLOGICAL ADVANCEMENTS IN INTERVENTIONAL DEVICES ....... 48
4.3 RESTRAINTS .................... 50
4.3.1 SAFETY CONCERNS AND LITIGATION RELATED TO SLING/MESH DEVICES ....... 50
4.3.2 LIMITED REIMBURSEMENT POLICIES ................... 50
4.3.3 SOCIAL STIGMA AND UNDERDIAGNOSIS .............. 51
4.4 OPPORTUNITIES ............... 52
4.4.1 GROWTH OF AMBULATORY SURGICAL CENTERS ............................................. 52
4.4.2 INNOVATION IN ARTIFICIAL URINARY SPHINCTERS AND SMART DEVICES ....... 52
5 MARKET FACTOR ANALYSIS ................................. 53
5.1 REGULATORY ENVIRONMENT & COMPLIANCE .............. 53
5.2 TECHNOLOGICAL TRENDS & INNOVATION ................... 54
5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS ........... 55
5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS ...... 56
5.4.1 NORTH AMERICA ..... 56
5.4.2 EUROPE ................... 56
5.4.3 ASIA-PACIFIC ........... 56
5.4.4 SOUTH AMERICA ...... 56
5.4.5 MIDDLE EAST & AFRICA ....................................... 56
5.4.6 REIMBURSEMENT DYNAMICS .............................. 57
5.5 MARKET ENTRY & EXIT BARRIERS ................................ 58
5.5.1 BARRIERS TO ENTRY ........................................... 58
5.5.2 BARRIERS TO EXIT ............................................... 58
5.6 PARTNERSHIPS & COLLABORATIONS ........................... 59
5.7 CONSUMER & HEALTHCARE PROVIDER PREFERENCES ............................................ 60
5.7.1 CONSUMER PREFERENCES .................................. 60
5.7.2 HEALTHCARE PROVIDER PREFERENCES ............... 60
5.8 PESTLE ANALYSIS ............ 61
5.8.1 POLITICAL FACTORS ........................................... 61
5.8.2 ECONOMIC FACTORS .......................................... 61
5.8.3 SOCIAL FACTORS ..... 61
5.8.4 TECHNOLOGICAL FACTORS ................................. 61
5.8.5 LEGAL FACTORS ...... 62
5.8.6 ENVIRONMENTAL FACTORS ................................ 62
5.9 PORTER'S FIVE FORCES MODEL ................................... 63
5.9.1 THREAT OF NEW ENTRANTS ................................ 64
5.9.2 BARGAINING POWER OF SUPPLIERS .................... 64
5.9.3 THREAT OF SUBSTITUTES ................................... 64
5.9.4 BARGAINING POWER OF BUYERS ......................... 64
5.9.5 INTENSITY OF RIVALRY ....................................... 64
5.10 PRODUCT PIPELINE ANALYSIS ..................................... 65
5.11 CASE STUDY ANALYSIS ............................................... 66
5.12 INVESTMENT & FUNDING SCENARIOS .......................... 67
5.13 POST-MARKET SURVEILLANCE & SAFETY DATA ........... 68
5.14 DISEASE OVERVIEW .......... 69
5.15 DIAGNOSIS ....................... 70
5.16 CURRENT TREATMENT ..... 71
6 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE ........................................ 73
6.1 OVERVIEW ....................... 73
6.2 THERAPEUTIC OR INTERVENTIONAL DEVICES .............. 75
6.2.1 URETHRAL SLINGS .............................................. 76
6.2.1.1 MIDURETHRAL SLINGS ......................................... 77
6.2.1.2 AUTOLOGOUS SLINGS .......................................... 77
6.2.2 ARTIFICIAL URINARY SPHINCTERS ....................... 78
6.2.3 URETHRAL BULKING AGENTS .............................. 78
6.2.4 PESSARIES ............... 79
6.2.5 DISPOSABLE VAGINAL INSERTS ........................... 79
6.2.6 OTHERS ................... 80
6.3 ABSORBENT PRODUCTS .............................................. 80
6.3.1 ADULT DIAPERS ....... 81
6.3.2 ABSORBENT PADS............................................... 82
6.3.3 PROTECTIVE UNDERWEAR ................................... 82
6.3.4 DRIP COLLECTORS .............................................. 83
7 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY END USER ....... 84
7.1 OVERVIEW ....................... 84
7.2 HOSPITALS ...................... 86
7.3 SPECIALTY CLINICS ......... 87
7.4 AMBULATORY SURGICAL CENTERS .............................. 87
7.5 HOME CARE SETTINGS ..... 88
7.6 OTHERS ........................... 88
8 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY REGION............ 89
8.1 OVERVIEW ....................... 89
8.2 NORTH AMERICA .............. 91
8.2.1 US ........................... 96
8.2.2 CANADA .................. 99
8.3 EUROPE ........................... 102
8.3.1 GERMANY ................ 107
8.3.2 UK ........................... 110
8.3.3 FRANCE ................... 113
8.3.4 NETHERLANDS ......... 116
8.3.5 ITALY ....................... 119
8.3.6 SPAIN ...................... 122
8.3.7 REST OF EUROPE ...... 125
8.4 ASIA-PACIFIC ................... 128
8.4.1 CHINA ...................... 133
8.4.2 INDIA ....................... 136
8.4.3 JAPAN ..................... 139
8.4.4 SOUTH KOREA .......... 142
8.4.5 MALAYSIA ............... 145
8.4.6 THAILAND ................ 148
8.4.7 INDONESIA .............. 151
8.4.8 REST OF ASIA-PACIFIC ........................................ 154
8.5 LATIN AMERICA ............... 157
8.5.1 BRAZIL ..................... 162
8.5.2 MEXICO ................... 165
8.5.3 ARGENTINA ............. 168
8.5.4 REST OF LATIN AMERICA ..................................... 171
8.6 MIDDLE EAST & AFRICA ............................................... 174
8.6.1 GCC COUNTRIES ...... 178
8.6.2 SOUTH AFRICA ......... 181
8.6.3 REST OF MIDDLE EAST & AFRICA ......................... 184
9 COMPETITIVE LANDSCAPE ................................... 188
9.1 INTRODUCTION ................ 188
9.2 MARKET SHARE ANALYSIS, 2025 ................................. 188
9.3 COMPETITOR DASHBOARD .......................................... 189
9.4 PUBLIC PLAYERS STOCK SUMMARY ............................ 190
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ............................................... 190
9.6 KEY DEVELOPMENTS ........ 191
10 COMPANY PROFILES ............................................. 193
10.1 BOSTON SCIENTIFIC CORPORATION ............................ 193
10.1.1 COMPANY OVERVIEW .......................................... 193
10.1.2 FINANCIAL OVERVIEW ......................................... 194
10.1.3 PRODUCTS OFFERED ........................................... 194
10.1.4 SWOT ANALYSIS ...... 195
10.1.5 KEY STRATEGIES ...... 196
10.2 COLOPLAST A/S ............... 197
10.2.1 COMPANY OVERVIEW .......................................... 197
10.2.2 FINANCIAL OVERVIEW ......................................... 198
10.2.3 PRODUCTS OFFERED ........................................... 199
10.2.4 SWOT ANALYSIS ...... 199
10.2.5 KEY STRATEGIES ...... 200
10.3 LABORIE .......................... 201
10.3.1 COMPANY OVERVIEW .......................................... 201
10.3.2 PRODUCTS OFFERED ........................................... 202
10.3.3 SWOT ANALYSIS ...... 203
10.3.4 KEY STRATEGY ......... 203
10.4 CALDERA MEDICAL .......... 204
10.4.1 COMPANY OVERVIEW .......................................... 204
10.4.2 PRODUCTS OFFERED ........................................... 205
10.4.3 SWOT ANALYSIS ...... 205
10.4.4 KEY STRATEGY ......... 206
10.5 NEOMEDIC INTERNATIONAL ........................................ 207
10.5.1 COMPANY OVERVIEW .......................................... 207
10.5.2 PRODUCTS OFFERED ........................................... 208
10.5.3 SWOT ANALYSIS ...... 208
10.5.4 KEY STRATEGY ......... 209
10.6 ZEPHYR SURGICAL IMPLANTS ..................................... 210
10.6.1 COMPANY OVERVIEW .......................................... 210
10.6.2 PRODUCTS OFFERED ........................................... 211
10.6.3 SWOT ANALYSIS ...... 211
10.6.4 KEY STRATEGY ......... 212
10.7 MERZ PHARMACEUTICALS, LLC ................................... 213
10.7.1 COMPANY OVERVIEW .......................................... 213
10.7.2 PRODUCTS OFFERED ........................................... 214
10.7.3 SWOT ANALYSIS ...... 214
10.7.4 KEY STRATEGY ......... 215
10.8 KIMBERLY-CLARK ............. 216
10.8.1 COMPANY OVERVIEW .......................................... 216
10.8.2 FINANCIAL OVERVIEW ......................................... 217
10.8.3 PRODUCTS OFFERED ........................................... 217
10.8.4 KEY DEVELOPMENTS .......................................... 219
10.8.5 SWOT ANALYSIS ...... 219
10.8.6 KEY STRATEGIES ...... 220
10.9 ONTEX ............................. 221
10.9.1 COMPANY OVERVIEW .......................................... 221
10.9.2 FINANCIAL OVERVIEW ......................................... 222
10.9.3 PRODUCTS OFFERED ........................................... 222
10.9.4 KEY DEVELOPMENTS .......................................... 223
10.9.5 SWOT ANALYSIS ...... 224
10.9.6 KEY STRATEGIES ...... 224
10.10 CL MEDICAL ..................... 225
10.10.1 COMPANY OVERVIEW .......................................... 225
10.10.2 FINANCIAL OVERVIEW ......................................... 226
10.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ........ 226
10.10.4 KEY DEVELOPMENTS .......................................... 226
10.10.5 SWOT ANALYSIS ...... 227
10.10.6 KEY STRATEGIES ...... 227
11 DATA CITATIONS .......... 228

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 43
TABLE 2 PRODUCT PIPELINE 65
TABLE 3 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 74
TABLE 4 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY REGION, 2019-H-2035
(USD MILLION) 75
TABLE 5 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 75
TABLE 6 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY REGION, 2019-H-2035 (USD MILLION) 76
TABLE 7 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 76
TABLE 8 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR MIDURETHRAL SLINGS, BY REGION, 2019-H-2035 (USD MILLION) 77
TABLE 9 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR AUTOLOGOUS SLINGS, BY REGION, 2019-H-2035 (USD MILLION) 77
TABLE 10 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2019-H-2035 (USD MILLION)
78
TABLE 11 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL BULKING AGENTS, BY REGION, 2019-H-2035 (USD MILLION)
78
TABLE 12 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR PESSARIES, BY REGION, 2019-H-2035 (USD MILLION) 79
TABLE 13 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR DISPOSABLE VAGINAL INSERTS, BY REGION, 2019-H-2035 (USD MILLION)
79
TABLE 14 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR OTHERS, BY REGION, 2019-H-2035 (USD MILLION) 80
TABLE 15 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY REGION, 2019-H-2035 (USD MILLION) 80
TABLE 16 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 81
TABLE 17 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR ADULT DIAPERS, BY REGION, 2019-H-2035 (USD MILLION) 81
TABLE 18 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PADS, BY REGION, 2019-H-2035 (USD MILLION) 82
TABLE 19 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR PROTECTIVE UNDERWEAR, BY REGION, 2019-H-2035 (USD MILLION) 82
TABLE 20 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR DRIP COLLECTORS, BY REGION, 2019-H-2035 (USD MILLION) 83
TABLE 21 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-2035 (USD MILLION) 85
TABLE 22 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR HOSPITALS, BY REGION, 2019-H-2035 (USD MILLION) 86
TABLE 23 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR SPECIALTY CLINICS , BY REGION, 2019-H-2035 (USD MILLION) 87
TABLE 24 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR AMBULATORY SURGICAL CENTERS , BY REGION, 2019-H-2035 (USD
MILLION) 87
TABLE 25 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR HOME CARE SETTINGS, BY REGION, 2019-H-2035 (USD MILLION) 88
TABLE 26 GLOBAL STRESS URINARY INCONTINENCE MARKET, FOR OTHERS, BY REGION, 2019-H-2035 (USD MILLION) 88
TABLE 27 GLOBAL STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 90
TABLE 28 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 92
TABLE 29 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 93
TABLE 30 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H
2035 (USD MILLION) 94
TABLE 31 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 94
TABLE 32 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
95
TABLE 33 NORTH AMERICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 95
TABLE 34 US STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 96
TABLE 35 US STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 96
TABLE 36 US STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 97
TABLE 37 US STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 97
TABLE 38 US STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 98
TABLE 39 CANADA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 99
TABLE 40 CANADA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 99
TABLE 41 CANADA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 100
TABLE 42 CANADA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 100
TABLE 43 CANADA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 101
TABLE 44 EUROPE STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 103
TABLE 45 EUROPE STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 104
TABLE 46 EUROPE STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 105
TABLE 47 EUROPE STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 105
TABLE 48 EUROPE STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 106
TABLE 49 EUROPE STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 106
TABLE 50 GERMANY STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 107
TABLE 51 GERMANY STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION) 107
TABLE 52 GERMANY STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 108
TABLE 53 GERMANY STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 108
TABLE 54 GERMANY STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 109
TABLE 55 UK STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 110
TABLE 56 UK STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 110
TABLE 57 UK STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 111
TABLE 58 UK STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 111
TABLE 59 UK STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 112
TABLE 60 FRANCE STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 113
TABLE 61 FRANCE STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 113
TABLE 62 FRANCE STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 114
TABLE 63 FRANCE STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 114
TABLE 64 FRANCE STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 115
TABLE 65 NETHERLANDS STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 116
TABLE 66 NETHERLANDS STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION) 116
TABLE 67 NETHERLANDS STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 117
TABLE 68 NETHERLANDS STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 117
TABLE 69 NETHERLANDS STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 118
TABLE 70 ITALY STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119
TABLE 71 ITALY STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 119
TABLE 72 ITALY STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 120
TABLE 73 ITALY STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 120
TABLE 74 ITALY STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 121
TABLE 75 SPAIN STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 122
TABLE 76 SPAIN STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 122
TABLE 77 SPAIN STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 123
TABLE 78 SPAIN STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 124
TABLE 79 SPAIN STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 124
TABLE 80 REST OF EUROPE STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 125
TABLE 81 REST OF EUROPE STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H
2035 (USD MILLION) 125
TABLE 82 REST OF EUROPE STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 126
TABLE 83 REST OF EUROPE STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
126
TABLE 84 REST OF EUROPE STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 127
TABLE 85 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 129
TABLE 86 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 130
TABLE 87 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION) 131
TABLE 88 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 131
TABLE 89 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 132
TABLE 90 ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 132
TABLE 91 CHINA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 133
TABLE 92 CHINA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 133
TABLE 93 CHINA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 134
TABLE 94 CHINA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 134
TABLE 95 CHINA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 135
TABLE 96 INDIA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 136
TABLE 97 INDIA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 136
TABLE 98 INDIA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 137
TABLE 99 INDIA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 137
TABLE 100 INDIA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 138
TABLE 101 JAPAN STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 139
TABLE 102 JAPAN STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION) 139
TABLE 103 JAPAN STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 140
TABLE 104 JAPAN STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 140
TABLE 105 JAPAN STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION) 141
TABLE 106 SOUTH KOREA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 142
TABLE 107 SOUTH KOREA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION) 142
TABLE 108 SOUTH KOREA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 143
TABLE 109 SOUTH KOREA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 143
TABLE 110 SOUTH KOREA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
144
TABLE 111 MALAYSIA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
145
TABLE 112 MALAYSIA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION)
145
TABLE 113 MALAYSIA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 114 MALAYSIA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 115 MALAYSIA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 116 THAILAND STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
146
TABLE 117 THAILAND STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION)
148
TABLE 118 THAILAND STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 119 THAILAND STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 120 THAILAND STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 121 INDONESIA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
149
TABLE 122 INDONESIA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION)
151
TABLE 123 INDONESIA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
152
TABLE 124 INDONESIA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 152
TABLE 125 INDONESIA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
153
TABLE 126 REST OF ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 127 REST OF ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE,
2019-H-2035 (USD MILLION)
154
TABLE 128 REST OF ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
155
TABLE 129 REST OF ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD
MILLION)
TABLE 130 REST OF ASIA-PACIFIC STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 131 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 132 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
155
TABLE 133 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H
2035 (USD MILLION)
160
TABLE 134 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
160
TABLE 135 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
161
TABLE 136 LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 137 BRAZIL STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
161
TABLE 138 BRAZIL STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION)
162
TABLE 139 BRAZIL STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 140 BRAZIL STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 141 BRAZIL STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 142 MEXICO STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
163
TABLE 143 MEXICO STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035 (USD
MILLION)
165
TABLE 144 MEXICO STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
166
TABLE 145 MEXICO STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
TABLE 146 MEXICO STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 147 ARGENTINA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
166
TABLE 148 ARGENTINA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION)
TABLE 149 ARGENTINA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
168
169
TABLE 150 ARGENTINA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 169
TABLE 151 ARGENTINA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
170
TABLE 152 REST OF LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
171
TABLE 153 REST OF LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE,
2019-H-2035 (USD MILLION)
171
TABLE 154 REST OF LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
172
TABLE 155 REST OF LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD
MILLION)
TABLE 156 REST OF LATIN AMERICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 157 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 158 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
172
TABLE 159 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE,
2019-H-2035 (USD MILLION)
176
TABLE 160 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
176
TABLE 161 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD
MILLION)
TABLE 162 MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 163 GCC COUNTRIES STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
177
TABLE 164 GCC COUNTRIES STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H
2035 (USD MILLION)
178
TABLE 165 GCC COUNTRIES STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION) 179
TABLE 166 GCC COUNTRIES STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION)
179
TABLE 167 GCC COUNTRIES STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 168 SOUTH AFRICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
180
TABLE 169 SOUTH AFRICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY TYPE, 2019-H-2035
(USD MILLION)
181
TABLE 170 SOUTH AFRICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD MILLION)
182
TABLE 171 SOUTH AFRICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035 (USD MILLION) 182
TABLE 172 SOUTH AFRICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
183
TABLE 173 REST OF MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 184
TABLE 174 REST OF MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR THERAPEUTIC OR INTERVENTIONAL DEVICES, BY
TYPE, 2019-H-2035 (USD MILLION)
184
TABLE 175 REST OF MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR URETHRAL SLINGS, BY TYPE, 2019-H-2035 (USD
MILLION)
185
TABLE 176 REST OF MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, FOR ABSORBENT PRODUCTS, BY TYPE, 2019-H-2035
(USD MILLION)
TABLE 177 REST OF MIDDLE EAST & AFRICA STRESS URINARY INCONTINENCE MARKET, BY END USER, 2019-H-2035 (USD MILLION)
TABLE 178 PUBLIC PLAYERS STOCK SUMMARY
TABLE 179 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 190
TABLE 180 KEY DEVELOPMENTS: GLOBAL STRESS URINARY INCONTINENCE MARKET 191
TABLE 181 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 194
TABLE 182 COLOPLAST A/S: PRODUCT OFFERED 199
TABLE 183 LABORIE: PRODUCT OFFERED 202
TABLE 184 CALDERA MEDICAL: PRODUCT OFFERED 205
TABLE 185 NEOMEDIC INTERNATIONAL: PRODUCT OFFERED 208
TABLE 186 ZEPHYR SURGICAL IMPLANTS: PRODUCT OFFERED 211
TABLE 187 MERZ PHARMACEUTICALS, LLC.: PRODUCT OFFERED 214
TABLE 188 KIMBERLY-CLARK: PRODUCTS OFFERED 217
TABLE 189 KIMBERLY-CLARK: KEY DEVELOPMENTS 219
TABLE 190 ONTEX: PRODUCTS OFFERED 222
TABLE 191 ONTEX: KEY DEVELOPMENTS 223
TABLE 192 CL MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 226